Methylphenidate is a stimulant medication commonly used to treat attention deficit hyperactivity disorder (ADHD) and certain ...

An open platform called GPCRmd-NMR combines molecular dynamics simulations with NMR spectroscopy to expose hidden ...

The FDA has approved Brytly (apraclonidine ophthalmic solution 0.125%) as an over-the-counter treatment for minor eye redness ...

The new research, published in ERJ Open Research, found that nearly one in five asthma patients and one in three COPD ...

BXCL501, a dexmedetomidine sublingual film, is under FDA review for first-ever at-home use for the acute treatment of agitation associated with ...

A new study shows that β3-adrenergic receptor activation drives profibrotic signaling in cardiac fibroblasts through ...

The FDA just approved Brytly, a nonprescription apraclonidine eye drop for red eyes. A doctor explains its use and potential ...

TONMYA improved Fibromyalgia Impact Questionnaire-Revised (FIQR) symptoms and function scores versus placebo in both domains at Week 14 in RELIEF ...

The medicine approved by AIFA complements auto-injectors: needle-free and just as effective, it is a life-saving treatment ...

Indenol and methylphenidate are prescription medications used for cardiovascular disease and attention-deficit hyperactivity ...

BXCL501, a dexmedetomidine sublingual film, is under FDA review for first-ever at-home use for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adultsAcqui ...

Psychological stress has long been associated with worsening symptoms in rheumatoid arthritis (RA). However, the underlying ...